During the past decade, KO-MED Centra Kliniczne Lublin II conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KO-MED Centra Kliniczne Lublin II" #1 sponsor was "Pfizer" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KO-MED Centra Kliniczne Lublin II" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "KO-MED Centra Kliniczne Lublin II" are "Dermatitis, Atopic" (4 trials), "Alzheimer Disease" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Cardiovascular Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "KO-MED Centra Kliniczne Lublin II" in a lesser frequency.

Most popular intervention types in "KO-MED Centra Kliniczne Lublin II" are "Drug" (26 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "PF-04965842 100 mg" (3 trials), "PF-04965842 200 mg" (3 trials), "Avelumab" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "KO-MED Centra Kliniczne Lublin II" are 28 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "KO-MED Centra Kliniczne Lublin II". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in KO-MED Centra Kliniczne Lublin II, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in KO-MED Centra Kliniczne Lublin II, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".